Italfarmaco, Givinostat, Duvyzat, Duchenne Muscular Dystrophy, DMD, EPIDYS, PUL 2.0, Upper Limb Function, World Muscle Society, WMS 2026, HDAC Inhibitor, Rare Disease,

MILAN, Italy — September 30, 2026 Italfarmaco S.p.A. presented new long-term data from the ongoing Phase 3 EPIDYS open-label...